User profiles for William C. Chapman

William C Chapman

Professor of Surgery, Washington University
Verified email at wustl.edu
Cited by 21906

A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy

ML Cheatham, WC Chapman, SP Key… - Annals of …, 1995 - journals.lww.com
… Address reprint requests to William C. Chapman, MD, Department of Surgery, 801 Oxford …
Obviously, the key question is, how do we predict that 1 patient in 20 who will benefit from the …

Comparison of the transcriptional landscapes between human and mouse tissues

…, C Zaleski, MA Beer, WC Chapman… - Proceedings of the …, 2014 - National Acad Sciences
Although the similarities between humans and mice are typically highlighted, morphologically
and genetically, there are many differences. To better understand these two species on a …

Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers

…, LM Kulik, JF Botha, JD Mezrich, WC Chapman… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Excellent single-center outcomes of neoadjuvant chemoradiation
and liver transplantation for unresectable perihilar cholangiocarcinoma caused the United …

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma

…, MH Rice, CW Pinson, WC Chapman… - Journal of …, 2004 - Elsevier
Our goal was to evaluate fluorodeoxyglucose (FDG) positron emission tomography (PET) in
staging patients with biliary tract cancers. Fifty consecutive patients who underwent FDG-…

Evaluation of benign vs malignant hepatic lesions with positron emission tomography

…, WH Martin, MP Sandler, WC Chapman… - Archives of …, 1998 - jamanetwork.com
Background In most malignant cells, the relatively low level of glucose-6-phosphatase leads
to accumulation and trapping of [ 18 F]fluorodeoxyglucose (FDG) intracellularly, allowing …

Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation

WC Chapman, MBM Doyle, JE Stuart… - Annals of …, 2008 - journals.lww.com
Purpose: To evaluate outcomes of downstaging patients with advanced (American liver
tumor study group stage III/IV) hepatocellular carcinoma (HCC) with transarterial …

Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1

…, JW Markmann, E Velidedeoglu, WC Chapman… - …, 2004 - journals.lww.com
Background. The Model for End-Stage Liver Disease (MELD) has been found to accurately
predict pretransplant mortality and is a valuable system for ranking patients in greatest need …

[PDF][PDF] Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma

D Delbeke, DM Rose, WC Chapman… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Methods: Sixty-five patients who presented with suspected pancreatic carcinoma underwent
whole-body FDG PET in addi tion to CT imaging. The PET ÂĄmageswere analyzed visually …

Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study

…, JP Debelak, TM Allos, Y Shyr, WC Chapman - Journal of Surgical …, 2002 - Elsevier
Introduction. An increased risk of gallstone (GS) formation has been linked to obesity and to
episodes of rapid and significant weight loss. Previous reports have suggested that bile salt …

18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer

…, D Delbeke, RD Beauchamp, WC Chapman… - Annals of …, 1999 - journals.lww.com
Objective To assess the accuracy and clinical impact of 18 fluorodeoxyglucose-positron
emission tomography (18 FDG-PET) on the management of patients with suspected primary or …